Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

1.

Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis.

Waters P, Jarius S, Littleton E, Leite MI, Jacob S, Gray B, Geraldes R, Vale T, Jacob A, Palace J, Maxwell S, Beeson D, Vincent A.

Arch Neurol. 2008 Jul;65(7):913-9. doi: 10.1001/archneur.65.7.913.

PMID:
18625857
[PubMed - indexed for MEDLINE]
2.

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.

Jarius S, Paul F, Franciotta D, Waters P, Zipp F, Hohlfeld R, Vincent A, Wildemann B.

Nat Clin Pract Neurol. 2008 Apr;4(4):202-14. doi: 10.1038/ncpneuro0764. Epub 2008 Mar 11. Review.

PMID:
18334978
[PubMed - indexed for MEDLINE]
3.

B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.

Levesque MC, St Clair EW.

J Allergy Clin Immunol. 2008 Jan;121(1):13-21; quiz 22-3. doi: 10.1016/j.jaci.2007.11.030. Review.

PMID:
18206502
[PubMed - indexed for MEDLINE]
4.

Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica.

Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, Lennon VA.

Neurology. 2007 Dec 11;69(24):2221-31. Epub 2007 Oct 10.

PMID:
17928579
[PubMed - indexed for MEDLINE]
5.

The spectrum of neuromyelitis optica.

Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG.

Lancet Neurol. 2007 Sep;6(9):805-15. Review.

PMID:
17706564
[PubMed - indexed for MEDLINE]
6.

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

Takahashi T, Fujihara K, Nakashima I, Misu T, Miyazawa I, Nakamura M, Watanabe S, Shiga Y, Kanaoka C, Fujimori J, Sato S, Itoyama Y.

Brain. 2007 May;130(Pt 5):1235-43. Epub 2007 Apr 19.

PMID:
17449477
[PubMed - indexed for MEDLINE]
Free Article
7.

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.

Paul F, Jarius S, Aktas O, Bluthner M, Bauer O, Appelhans H, Franciotta D, Bergamaschi R, Littleton E, Palace J, Seelig HP, Hohlfeld R, Vincent A, Zipp F.

PLoS Med. 2007 Apr;4(4):e133.

PMID:
17439296
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis.

Misu T, Fujihara K, Kakita A, Konno H, Nakamura M, Watanabe S, Takahashi T, Nakashima I, Takahashi H, Itoyama Y.

Brain. 2007 May;130(Pt 5):1224-34. Epub 2007 Apr 2.

PMID:
17405762
[PubMed - indexed for MEDLINE]
Free Article
9.

NMO-IgG in the diagnosis of neuromyelitis optica.

Jarius S, Franciotta D, Bergamaschi R, Wright H, Littleton E, Palace J, Hohlfeld R, Vincent A.

Neurology. 2007 Mar 27;68(13):1076-7. Epub 2007 Feb 7. No abstract available.

PMID:
17287449
[PubMed - indexed for MEDLINE]
10.

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.

Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF.

Brain. 2007 May;130(Pt 5):1194-205. Epub 2007 Feb 4.

PMID:
17282996
[PubMed - indexed for MEDLINE]
Free Article
11.

Revised diagnostic criteria for neuromyelitis optica.

Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG.

Neurology. 2006 May 23;66(10):1485-9.

PMID:
16717206
[PubMed - indexed for MEDLINE]
12.

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel.

Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR.

J Exp Med. 2005 Aug 15;202(4):473-7. Epub 2005 Aug 8.

PMID:
16087714
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

An open label study of the effects of rituximab in neuromyelitis optica.

Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C.

Neurology. 2005 Apr 12;64(7):1270-2.

PMID:
15824362
[PubMed - indexed for MEDLINE]
14.

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG.

Lancet. 2004 Dec 11-17;364(9451):2106-12.

PMID:
15589308
[PubMed - indexed for MEDLINE]
15.

Anti B cell therapy (rituximab) in the treatment of autoimmune diseases.

Kazkaz H, Isenberg D.

Curr Opin Pharmacol. 2004 Aug;4(4):398-402. Review.

PMID:
15251135
[PubMed - indexed for MEDLINE]
16.

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica.

Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H.

Brain. 2002 Jul;125(Pt 7):1450-61.

PMID:
12076996
[PubMed - indexed for MEDLINE]
Free Article
17.

Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile.

de Seze J, Stojkovic T, Ferriby D, Gauvrit JY, Montagne C, Mounier-Vehier F, Verier A, Pruvo JP, Hache JC, Vermersch P.

J Neurol Sci. 2002 May 15;197(1-2):57-61.

PMID:
11997067
[PubMed - indexed for MEDLINE]
18.

The clinical course of neuromyelitis optica (Devic's syndrome).

Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG.

Neurology. 1999 Sep 22;53(5):1107-14.

PMID:
10496275
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk